Biogen Inc at Leerink Global Healthcare Conference Transcript
All right, let's start back.
Thank you everybody for, joining us for our next session. We, I'm Mark Goodman, one of the biopharma analysts at Lang Partners, and we have BioGen next and very interesting head of West Coast Hub, Uktal Patel, I'll let him give a little bit of, background of how he got to the company and how this West Coast hub has been, started, but, very interesting for the company to do that, through this acquisition that you'll hear about. And obviously a very interesting asset that we're going to go through all the different indications and stuff, but I do think maybe just for sixty seconds just give your background and how the West Coast hub is like, what does it look like and how it's evolved, what the goals are.
Sure, well, my name's Zupal Patel, as Mark mentioned, thanks for having us and, be making some forward-looking statements. So just the usual disclaimers to look at the risks in our SEC filings, because those.
Results might
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

